Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213648) titled 'Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)' on Oct. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: University of Virginia
Condition:
Huntington Disease
Parkinson Disease
Intervention:
Behavioral: MindTrails-Movement
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 2025
Target Sample Size: 136
Countries of Recruitment:
United States
To know more, visit https://clinical...